Always document the drug name (including NDC number where required), the dose administered, and whether the route was subcutaneous, intramuscular, or intra-arterial
When Switching Makes Sense and When It Doesnt Switching to tirzepatide may be a good option if: Weight loss has stalled despite consistency Side effects are limiting progress Appetite control remains a challenge Staying on semaglutide may make sense if: Weight loss is steady Side effects are minimal The current dose is working well The right choice depends on how your body is responding, not on comparisons alone
After the initial deductible ($590 in 2025), patients enter the initial coverage phase with tiered copays
A blinded extension among participants with baseline BMI 35 reached 30.3% mean weight loss at 104 weeks
For a broader look at the role of treatment selection in a telehealth program, you can also read how to order GLP-1 medications for effective weight loss
We recommend you get booster shots routinely to avoid the impacts from fading
